1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS AND EXCLUSIONS 26
1.3 MARKET SCOPE 27
1.3.1 MARKETS COVERED 27
FIGURE 1 ULTRASOUND NEEDLE GUIDES MARKET SEGMENTATION 27
1.3.2 YEARS CONSIDERED 27
1.4 CURRENCY CONSIDERED 28
TABLE 1 STANDARD CURRENCY CONVERSION RATES 28
1.5 STAKEHOLDERS 28
1.6 RECESSION IMPACT 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 2 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA 29
2.1.1.1 Key data from secondary sources 30
2.1.2 PRIMARY DATA 31
FIGURE 3 PRIMARY SOURCES 31
2.1.2.1 Key data from primary sources 32
2.1.2.2 Key industry insights 32
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 33
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 33
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 34
2.2 MARKET SIZE ESTIMATION 34
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 34
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: ROPER TECHNOLOGIES (CIVCO MEDICAL SOLUTIONS) 35
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: ULTRASOUND NEEDLE GUIDES MARKET (2021) 36
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027) 37
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 38
FIGURE 12 TOP-DOWN APPROACH 38
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 39
FIGURE 13 DATA TRIANGULATION METHODOLOGY 39
2.4 MARKET SHARE ESTIMATION 40
2.5 STUDY ASSUMPTIONS 40
2.6 LIMITATIONS 40
2.6.1 METHODOLOGY-RELATED LIMITATIONS 40
2.6.2 SCOPE-RELATED LIMITATIONS 40
2.7 RISK ASSESSMENT 41
TABLE 2 RISK ASSESSMENT: ULTRASOUND NEEDLE GUIDES MARKET 41
2.8 IMPACT OF RECESSION ON ULTRASOUND NEEDLE GUIDES MARKET 41
3 EXECUTIVE SUMMARY 42
FIGURE 14 ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 42
FIGURE 15 ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 43
FIGURE 16 ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 43
FIGURE 17 GEOGRAPHIC SNAPSHOT OF ULTRASOUND NEEDLE GUIDES MARKET 44
4 PREMIUM INSIGHTS 45
4.1 ULTRASOUND NEEDLE GUIDES MARKET OVERVIEW 45
FIGURE 18 INCREASING DEMAND FOR ULTRASOUND PROCEDURES TO DRIVE MARKET GROWTH 45
4.2 ASIA PACIFIC: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE AND COUNTRY 46
FIGURE 19 DISPOSABLE NEEDLE GUIDES SEGMENT HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021 46
4.3 ULTRASOUND NEEDLE GUIDES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47
FIGURE 20 MARKET IN ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 47
4.4 ULTRASOUND NEEDLE GUIDES MARKET: REGIONAL MIX 47
FIGURE 21 NORTH AMERICA WOULD BE LARGEST MARKET FOR ULTRASOUND NEEDLE GUIDES THROUGHOUT FORECAST PERIOD 47
4.5 ULTRASOUND NEEDLE GUIDES MARKET: DEVELOPED VS. DEVELOPING MARKETS 48
FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
FIGURE 23 ULTRASOUND NEEDLE GUIDES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
5.2.1 DRIVERS 50
5.2.1.1 Increasing prevalence of target diseases 50
TABLE 3 GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65–85+), 2020 VS. 2040 50
5.2.1.2 Increasing preference for minimally invasive biopsies 51
5.2.1.3 Increasing adoption of ultrasound imaging 51
5.2.1.4 Advantages offered by needle guides 52
5.2.2 RESTRAINTS 52
5.2.2.1 Risk of infections associated with use of aspiration and biopsy needles 52
5.2.2.2 Limited reimbursement in developing countries 52
5.2.3 OPPORTUNITIES 53
5.2.3.1 Growth opportunities in emerging economies 53
TABLE 4 RISING INCOME LEVELS IN EMERGING COUNTRIES 54
FIGURE 24 GDP GROWTH FORECAST: COMPARISON AMONG INDIA, CHINA, US, AND GERMANY, 2020 VS. 2040 (FORECAST) 54
5.2.4 CHALLENGES 54
5.2.4.1 Limited number of skilled medical professionals 54
5.3 INDUSTRY TRENDS 55
5.3.1 NEEDLE TIP TRACKING TECHNOLOGY 55
5.4 TARIFF AND REGULATORY LANDSCAPE 55
5.4.1 REGULATORY ANALYSIS 55
5.4.1.1 North America 55
5.4.1.1.1 US 55
TABLE 5 US FDA: THREE MAIN CLASSIFICATIONS OF MEDICAL DEVICES 56
FIGURE 25 US PREMARKET NOTIFICATION: 510(K) APPROVAL PROCESS FOR MEDICAL DEVICES 56
5.4.1.1.2 Canada 56
FIGURE 26 CANADA: APPROVAL PROCESS FOR CLASS II MEDICAL DEVICES 57
5.4.1.2 Europe 57
FIGURE 27 EUROPE: CE MARK APPROVAL PROCESS FOR ULTRASOUND NEEDLE GUIDES 57
5.4.1.3 Asia Pacific 58
5.4.1.3.1 Australia 58
5.4.1.3.2 Japan 58
TABLE 6 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY 58
5.4.1.3.3 India 59
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 59
TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 59
TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 59
TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 10 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
TABLE 11 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 60
5.5 VALUE CHAIN ANALYSIS 61
FIGURE 28 ULTRASOUND NEEDLE GUIDES MARKET: VALUE CHAIN ANALYSIS 61
5.6 SUPPLY CHAIN ANALYSIS 61
FIGURE 29 ULTRASOUND NEEDLE GUIDES MARKET: SUPPLY CHAIN ANALYSIS 62
5.7 ECOSYSTEM MARKET MAP 63
FIGURE 30 ULTRASOUND NEEDLE GUIDES MARKET: ECOSYSTEM MARKET MAP 63
5.8 PORTER’S FIVE FORCES ANALYSIS 63
5.8.1 THREAT OF NEW ENTRANTS 64
5.8.2 THREAT OF SUBSTITUTES 64
5.8.3 BARGAINING POWER OF SUPPLIERS 64
5.8.4 BARGAINING POWER OF BUYERS 64
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 64
5.9 PATENT ANALYSIS 65
5.9.1 PATENT PUBLICATION TRENDS FOR ULTRASOUND NEEDLE GUIDES 65
FIGURE 31 PATENT PUBLICATION TRENDS (JANUARY 2012–JANUARY 2023) 65
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 65
FIGURE 32 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ULTRASOUND NEEDLE GUIDE PATENTS, JANUARY 2012–JANUARY 2023 66
FIGURE 33 TOP 10 APPLICANT COUNTRIES/REGIONS FOR ULTRASOUND NEEDLE GUIDE PATENTS (JANUARY 2012–JANUARY 2023) 66
TABLE 12 ULTRASOUND NEEDLE GUIDES: LIST OF MAJOR PATENTS 67
5.10 TECHNOLOGY ANALYSIS 68
5.10.1 ROBOTIC ASSISTANCE 68
5.10.2 IMAGE-BASED NEEDLE TRACKING 68
5.11 INDICATIVE PRICING MODEL ANALYSIS 68
TABLE 13 AVERAGE SELLING PRICE OF ULTRASOUND NEEDLE GUIDES (2022) 69
5.11.1 AVERAGE SELLING PRICE TRENDS 69
5.12 KEY CONFERENCES AND EVENTS IN 2022–2023 69
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 70
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 70
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ULTRASOUND NEEDLE GUIDES 70
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ULTRASOUND NEEDLE GUIDES 70
5.13.2 BUYING CRITERIA 70
FIGURE 35 KEY BUYING CRITERIA FOR ULTRASOUND NEEDLE GUIDES 70
TABLE 15 KEY BUYING CRITERIA FOR ULTRASOUND NEEDLE GUIDES 71
6 ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE 72
6.1 INTRODUCTION 73
TABLE 16 ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 73
6.2 DISPOSABLE NEEDLE GUIDES 73
6.2.1 INCREASING HEALTHCARE AWARENESS TO DRIVE GROWTH 73
TABLE 17 DISPOSABLE ULTRASOUND NEEDLE GUIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74
6.3 REUSABLE NEEDLE GUIDES 74
6.3.1 HIGHER PREFERENCE FOR DISPOSABLE NEEDLE GUIDES DUE TO LOWER RISK OF INFECTION TO RESTRAIN MARKET GROWTH 74
TABLE 18 REUSABLE ULTRASOUND NEEDLE GUIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 75
7 ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION 76
7.1 INTRODUCTION 77
TABLE 19 ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 77
7.2 TISSUE BIOPSY 77
7.2.1 NEEDLE GUIDES ENSURE BETTER SAFETY OF PATIENTS DURING BIOPSY PROCEDURES 77
TABLE 20 ULTRASOUND NEEDLE GUIDES MARKET FOR TISSUE BIOPSY, BY COUNTRY, 2020–2027 (USD MILLION) 78
7.3 FLUID ASPIRATION 78
7.3.1 INCREASING NUMBER OF SURGERIES TO DRIVE GROWTH 78
TABLE 21 ULTRASOUND NEEDLE GUIDES MARKET FOR FLUID ASPIRATION, BY COUNTRY, 2020–2027 (USD MILLION) 79
7.4 VASCULAR ACCESS PROCEDURES 79
7.4.1 NEEDLE GUIDES IMPROVE NEEDLE PLACEMENT DURING VASCULAR ACCESS PROCEDURES 79
TABLE 22 ULTRASOUND NEEDLE GUIDES MARKET FOR VASCULAR ACCESS PROCEDURES, BY COUNTRY, 2020–2027 (USD MILLION) 80
7.5 NERVE BLOCK AND REGIONAL ANESTHESIA 80
7.5.1 NEEDLE GUIDES ENSURE PLACEMENT OF NEEDLE TIP WITHIN SCAN PLANE DURING NERVE BLOCK AND REGIONAL ANESTHESIA PROCEDURES 80
TABLE 23 ULTRASOUND NEEDLE GUIDES MARKET FOR NERVE BLOCK AND REGIONAL ANESTHESIA, BY COUNTRY, 2020–2027 (USD MILLION) 81
7.6 OTHER APPLICATIONS 82
TABLE 24 ULTRASOUND NEEDLE GUIDES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 82
8 ULTRASOUND NEEDLE GUIDES MARKET, BY END USER 83
8.1 INTRODUCTION 84
TABLE 25 ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 84
8.2 HOSPITALS AND CLINICS 84
8.2.1 HOSPITALS PERFORM LARGE NUMBER OF ULTRASOUND-BASED MEDICAL PROCEDURES 84
TABLE 26 ULTRASOUND NEEDLE GUIDES MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 85
8.3 AMBULATORY SURGICAL CENTERS 85
8.3.1 INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE GROWTH 85
TABLE 27 ULTRASOUND NEEDLE GUIDES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 86
8.4 DIAGNOSTIC IMAGING CENTERS 87
8.4.1 INCREASED DEMAND FOR EARLY DIAGNOSIS TO DRIVE MARKET 87
TABLE 28 ULTRASOUND NEEDLE GUIDES MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 87
8.5 OTHER END USERS 88
TABLE 29 ULTRASOUND NEEDLE GUIDES MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 88
9 ULTRASOUND NEEDLE GUIDES MARKET, BY REGION 89
9.1 INTRODUCTION 90
FIGURE 36 ULTRASOUND NEEDLE GUIDES MARKET: GEOGRAPHIC SNAPSHOT 90
TABLE 30 ULTRASOUND NEEDLE GUIDES MARKET, BY REGION, 2020–2027 (USD MILLION) 91
9.2 NORTH AMERICA 91
9.2.1 IMPACT OF RECESSION ON ULTRASOUND NEEDLE GUIDES MARKET IN NORTH AMERICA 91
FIGURE 37 NORTH AMERICA: ULTRASOUND NEEDLE GUIDES MARKET SNAPSHOT 92
TABLE 31 NORTH AMERICA: ULTRASOUND NEEDLE GUIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92
TABLE 32 NORTH AMERICA: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
TABLE 33 NORTH AMERICA: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93
TABLE 34 NORTH AMERICA: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 93
9.2.2 US 94
9.2.2.1 US to dominate North American ultrasound needle guides market during forecast period 94
TABLE 35 US: KEY MACROINDICATORS 94
TABLE 36 US: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 95
TABLE 37 US: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 95
TABLE 38 US: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 95
9.2.3 CANADA 96
9.2.3.1 Growing awareness about early disease diagnosis to drive market growth 96
TABLE 39 CANADA: KEY MACROINDICATORS 96
TABLE 40 CANADA: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 96
TABLE 41 CANADA: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 97
TABLE 42 CANADA: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 97
9.3 EUROPE 97
9.3.1 IMPACT OF RECESSION ON ULTRASOUND NEEDLE GUIDES MARKET IN EUROPE 97
TABLE 43 EUROPE: ULTRASOUND NEEDLE GUIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98
TABLE 44 EUROPE: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 45 EUROPE: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 99
TABLE 46 EUROPE: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 99
9.3.2 GERMANY 99
9.3.2.1 Germany held largest share of European ultrasound needle guides market in 2021 99
TABLE 47 GERMANY: KEY MACROINDICATORS 100
TABLE 48 GERMANY: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 100
TABLE 49 GERMANY: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 100
TABLE 50 GERMANY: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 101
9.3.3 FRANCE 101
9.3.3.1 Modernization of healthcare infrastructure fueling market growth 101
TABLE 51 FRANCE: KEY MACROINDICATORS 101
TABLE 52 FRANCE: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 102
TABLE 53 FRANCE: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 102
TABLE 54 FRANCE: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 102
9.3.4 UK 103
9.3.4.1 Rising geriatric population to drive market growth 103
TABLE 55 UK: KEY MACROINDICATORS 103
TABLE 56 UK: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 103
TABLE 57 UK: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 104
TABLE 58 UK: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 104
9.3.5 ITALY 104
9.3.5.1 Improved reimbursement scenario to support overall market growth 104
TABLE 59 ITALY: KEY MACROINDICATORS 105
TABLE 60 ITALY: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 61 ITALY: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105
TABLE 62 ITALY: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 106
9.3.6 SPAIN 106
9.3.6.1 Developing healthcare facilities and infrastructure to drive growth 106
TABLE 63 SPAIN: KEY MACROINDICATORS 106
TABLE 64 SPAIN: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 65 SPAIN: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107
TABLE 66 SPAIN: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 107
9.3.7 REST OF EUROPE 108
TABLE 67 REST OF EUROPE: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 108
TABLE 68 REST OF EUROPE: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 108
TABLE 69 REST OF EUROPE: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 109
9.4 ASIA PACIFIC 109
9.4.1 IMPACT OF RECESSION ON ULTRASOUND NEEDLE GUIDES MARKET IN ASIA PACIFIC 109
FIGURE 38 ASIA PACIFIC: ULTRASOUND NEEDLE GUIDES MARKET SNAPSHOT 110
TABLE 70 ASIA PACIFIC: ULTRASOUND NEEDLE GUIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 71 ASIA PACIFIC: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 111
TABLE 72 ASIA PACIFIC: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 111
TABLE 73 ASIA PACIFIC: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 112
9.4.2 CHINA 112
9.4.2.1 Increasing patient pool to drive market growth 112
TABLE 74 CHINA: KEY MACROINDICATORS 112
TABLE 75 CHINA: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 76 CHINA: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 77 CHINA: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 113
9.4.3 JAPAN 114
9.4.3.1 Rising geriatric population to drive market growth 114
TABLE 78 JAPAN: KEY MACROINDICATORS 114
TABLE 79 JAPAN: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 80 JAPAN: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115
TABLE 81 JAPAN: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 115
9.4.4 INDIA 115
9.4.4.1 Significant burden of target diseases and availability of affordable devices to drive market growth 115
TABLE 82 INDIA: KEY MACROINDICATORS 116
TABLE 83 INDIA: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 116
TABLE 84 INDIA: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 116
TABLE 85 INDIA: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 117
9.4.5 AUSTRALIA 117
9.4.5.1 Growing awareness campaigns to drive market growth 117
TABLE 86 AUSTRALIA: KEY MACROINDICATORS 117
TABLE 87 AUSTRALIA: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 88 AUSTRALIA: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 118
TABLE 89 AUSTRALIA: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 118
9.4.6 REST OF ASIA PACIFIC 119
TABLE 90 REST OF ASIA PACIFIC: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 91 REST OF ASIA PACIFIC: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119
TABLE 92 REST OF ASIA PACIFIC: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 120
9.5 LATIN AMERICA 120
9.5.1 IMPACT OF RECESSION ON ULTRASOUND NEEDLE GUIDES MARKET IN LATIN AMERICA 120
TABLE 93 LATIN AMERICA: ULTRASOUND NEEDLE GUIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 94 LATIN AMERICA: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 95 LATIN AMERICA: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 96 LATIN AMERICA: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 122
9.5.2 BRAZIL 122
9.5.2.1 Universal healthcare system to drive market growth 122
TABLE 97 BRAZIL: KEY MACROINDICATORS 122
TABLE 98 BRAZIL: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 123
TABLE 99 BRAZIL: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 123
TABLE 100 BRAZIL: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 123
9.5.3 MEXICO 124
9.5.3.1 Modernization of healthcare infrastructure to support market growth 124
TABLE 101 MEXICO: KEY MACROINDICATORS 124
TABLE 102 MEXICO: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 103 MEXICO: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 125
TABLE 104 MEXICO: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 125
9.5.4 REST OF LATIN AMERICA 125
TABLE 105 REST OF LATIN AMERICA: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 126
TABLE 106 REST OF LATIN AMERICA: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 126
TABLE 107 REST OF LATIN AMERICA: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 126
9.6 MIDDLE EAST & AFRICA 127
9.6.1 IMPACT OF RECESSION ON ULTRASOUND NEEDLE GUIDES MARKET IN MIDDLE EAST & AFRICA 127
TABLE 108 MIDDLE EAST & AFRICA: ULTRASOUND NEEDLE GUIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 109 MIDDLE EAST & AFRICA: ULTRASOUND NEEDLE GUIDES MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 110 MIDDLE EAST & AFRICA: ULTRASOUND NEEDLE GUIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 128
10 COMPETITIVE LANDSCAPE 129
10.1 INTRODUCTION 129
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 129
10.3 REVENUE ANALYSIS OF KEY MARKET PLAYERS 129
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN ULTRASOUND NEEDLE GUIDES MARKET 130
10.4 MARKET SHARE ANALYSIS 130
FIGURE 40 ULTRASOUND NEEDLE GUIDES MARKET SHARE, BY KEY PLAYER (2021) 130
10.5 COMPANY FOOTPRINT ANALYSIS 131
10.5.1 FOOTPRINT OF COMPANIES, BY TYPE 131
10.5.2 FOOTPRINT OF COMPANIES, BY APPLICATION 131
10.5.3 FOOTPRINT OF COMPANIES, BY REGION 132
10.6 COMPANY EVALUATION MATRIX 133
10.6.1 STARS 133
10.6.2 EMERGING LEADERS 133
10.6.3 PERVASIVE PLAYERS 133
10.6.4 PARTICIPANTS 134
FIGURE 41 ULTRASOUND NEEDLE GUIDES MARKET: COMPANY EVALUATION MATRIX 134
10.7 COMPETITIVE BENCHMARKING 135
TABLE 111 ULTRASOUND NEEDLE GUIDES MARKET: KEY START-UPS/SMES 135
10.8 COMPETITIVE SCENARIO 135
10.8.1 DEALS 135
TABLE 112 ULTRASOUND NEEDLE GUIDES MARKET: DEALS (JANUARY 2019–JANUARY 2023) 135
11 COMPANY PROFILES 136
11.1 KEY PLAYERS 136
(Business overview, Products offered, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats)*
11.1.1 CIVCO MEDICAL SOLUTIONS (A ROPER COMPANY) 136
TABLE 113 CIVCO MEDICAL SOLUTIONS: BUSINESS OVERVIEW 136
FIGURE 42 COMPANY SNAPSHOT: ROPER TECHNOLOGIES, INC. (2021) 137
11.1.2 BECTON, DICKINSON AND COMPANY 140
TABLE 114 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 140
FIGURE 43 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2022) 141
11.1.3 ASPEN SURGICAL 143
TABLE 115 ASPEN SURGICAL: BUSINESS OVERVIEW 143
11.1.4 ARGON MEDICAL DEVICES 145
TABLE 116 ARGON MEDICAL DEVICES: BUSINESS OVERVIEW 145
11.1.5 FUJIFILM SONOSITE, INC. (A PART OF FUJIFILM HOLDINGS CORPORATION) 147
TABLE 117 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 147
FIGURE 44 COMPANY SNAPSHOT: FUJIFILM HOLDINGS CORPORATION (2021) 148
11.1.6 ROCKET MEDICAL 150
TABLE 118 ROCKET MEDICAL: BUSINESS OVERVIEW 150
11.1.7 SIEMENS HEALTHINEERS AG 151
TABLE 119 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 151
FIGURE 45 COMPANY SNAPSHOT: SIEMENS HEALTHINEERS (2021) 152
11.1.8 HOLOGIC, INC. 153
TABLE 120 HOLOGIC, INC.: BUSINESS OVERVIEW 153
FIGURE 46 COMPANY SNAPSHOT: HOLOGIC, INC. (2021) 154
11.1.9 REMINGTON MEDICAL INC. 155
TABLE 121 REMINGTON MEDICAL INC.: BUSINESS OVERVIEW 155
11.1.10 GEOTEK MEDICAL 156
TABLE 122 GEOTEK MEDICAL: BUSINESS OVERVIEW 156
11.2 OTHER PLAYERS 157
11.2.1 INNOFINE 157
TABLE 123 INNOFINE: BUSINESS OVERVIEW 157
11.2.2 KOELIS 158
TABLE 124 KOELIS: BUSINESS OVERVIEW 158
11.2.3 BIRR 159
TABLE 125 BIRR: BUSINESS OVERVIEW 159
11.2.4 IZI MEDICAL 160
TABLE 126 IZI MEDICAL: BUSINESS OVERVIEW 160
11.2.5 SHEATHING TECHNOLOGIES, INC. 161
TABLE 127 SHEATHING TECHNOLOGIES, INC.: BUSINESS OVERVIEW 161
11.2.6 WELLGO MEDICAL PRODUCTS GMBH 162
TABLE 128 WELLGO MEDICAL PRODUCTS GMBH: BUSINESS OVERVIEW 162
11.2.7 ADVANCE MEDICAL DESIGNS, INC. 163
TABLE 129 ADVANCE MEDICAL DESIGNS, INC: BUSINESS OVERVIEW 163
*Details on Business overview, Products offered, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 164
12.1 DISCUSSION GUIDE 164
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 168
12.3 CUSTOMIZATION OPTIONS 170
12.4 RELATED REPORTS 170
12.5 AUTHOR DETAILS 171
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer